Skip to main content

Teva to buy Allergan's generics business for $40.5B

Israel's Teva Pharmaceutical will buy Allergan's generic pharmaceuticals business for $40.5 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.